Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Michele G. Sullivan

News

Colchicine reduces inflammatory markers associated with metabolic syndrome

Author:
Michele G. Sullivan
Publish date: April 8, 2019

Colchicine was linked to lower levels of inflammatory markers and improved fasting insulin levels and glucose effectiveness.

  • Read More

News

Deuterium-altered ruxolitinib may be an effective treatment for alopecia areata

Author:
Michele G. Sullivan
Publish date: April 7, 2019

WASHINGTON – About half of those who took 8 mg of CPT-543, a chemically altered form of ruxolitinib, twice a day for 24 weeks, regrew hair –by at...

  • Read More

News

Abatacept appears safe for RA patients with COPD

Author:
Michele G. Sullivan
Publish date: April 5, 2019

A large prescription database review found no significantly increased risks of COPD exacerbation, pneumonia, flu, or bronchitis.

  • Read More

News

Amyloid brain imaging changed clinical management in 60% of MCI and dementia patients

Author:
Michele G. Sullivan

Results from IDEAS, a prospective imaging study, refined Alzheimer’s disease diagnoses in both amyloid-positive and amyloid-negative cases. Now it...

  • Read More

News

Corticosteroids: What is their place in pneumonia and sepsis?

Author:
Michele G. Sullivan
Publish date: March 26, 2019

Two experts drew on both personal experience and extant literature in the debate “Steroids for Pneumonia and Sepsis ... Do You Believe?”

  • Read More

News

Hospitalists can make a difference in disasters

Author:
Michele G. Sullivan
Publish date: March 26, 2019

When fire is eating entire neighborhoods, or a hurricane is smashing towns like toys, the hospitalist will...

  • Read More

News

Total plasma tau correlates with dementia onset, Alzheimer’s disease

Author:
Michele G. Sullivan

It’s not the Holy Grail of a simple Alzheimer’s blood test for the clinic. But it could be a big benefit in the...

  • Read More

News

BTK inhibitor calms pemphigus vulgaris with low-dose steroids

Author:
Michele G. Sullivan
Publish date: March 8, 2019

WASHINGTON – PRN1008 blocks BTK receptors on B cells, thus forestalling the B-cell mediated inflammatory cascade.

  • Read More

Opinion

IV ketamine, intranasal esketamine likely to ‘happily coexist’

Author:
Michele G. Sullivan
Publish date: March 6, 2019

“Initially, not every psychiatrist will be able to offer esketamine ... and that’s probably okay.”

  • Read More

News

FDA approves intranasal esketamine for refractory major depressive disorder

Author:
Michele G. Sullivan
Publish date: March 5, 2019

Under the FDA-required REMS, prescribers must complete specific training; the drug must be adminstered in office to allow for patient monitoring...

  • Read More

News

Bermekimab reduces lesions, cuts pain in patients with hidradenitis suppurativa

Author:
Michele G. Sullivan
Publish date: March 3, 2019

WASHINGTON – The human monoclonal antibody is the first to target interleukin-1 alpha in the disorder.

  • Read More

News

Many common dermatologic drugs can be safely used during pregnancy

Author:
Michele G. Sullivan
Publish date: March 3, 2019

WASHINGTON – With some caution, it’s possible to continue agents for psoriasis, atopic dermatitis, and pemphigus.

  • Read More

News

Texting improves postpregnancy hypertension monitoring in black women

Author:
Michele G. Sullivan
Publish date: March 2, 2019

LAS VEGAS – Compared with an office visit, the phone text system virtually eliminated the difference between the number of nonblack and black...

  • Read More

News

Selinexor hits FDA stumbling block

Author:
Michele G. Sullivan
Publish date: February 26, 2019

The Oncologic Drugs Advisory Committee expressed concern about the high rate of serious adverse events with the drug being developed to treat...

  • Read More

News

FDA: More safety data needed for 12 sunscreen active ingredients

Author:
Michele G. Sullivan
Publish date: February 21, 2019

Only two – titanium dioxide and zinc oxide – are generally recognized as safe and effective and not misbranded, officials said.

  • Read More

Pages

  • « first
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close